Company’s solutions speak to the unique transportation issues the pharmaceutical and biotech sectors face, including "last mile" delivery challenges and increasing regulatory requirements.

The pharma and medical sector's continuing to be a robust market for the packaging industry, forward-thinking solutions have come in a variety of areas. Read more about these solutions.

PA and PulPac created the Blister Pack Collective to limit the use of non-recyclable plastics in over-the-counter and prescription drug packaging through cross-industry collaboration.

The new solution is particularly relevant for sensitive mRNA-based substances as well as cell and gene therapies.

Diofan® Ultra736 is fluorine-free, meets regulatory requirements for direct pharmaceutical contact and supports the design of sustainable films with thinner coating designs. 

At Booth 2G19, the company will highlight the Pentafill® A25 Filling & Sealing Machine, which offers several improvements over previous models, including improved sterility and a smaller footprint.

In this article, two experts talk about the importance of proper transit packaging in delivering the convenience and quality that consumers desire from digital grocery.

Expanded recycled polymer offering at former oil refinery will target the high-performance packaging market, particularly packaging for pharmaceuticals and cosmetics.

In this podcast, we talk about secondary packaging solutions for the food industry, pharmaceuticals and medical devices, and the personal care and beauty industry.

Antares Vision Group becomes first DSCSA solution provider to join the Pulse Interoperable Partner program of the National Association of Boards of Pharmacy (NABP).